We aim to create a new way to fight cancer, with uncompromised Science, Passion & Commitment
Rakuten Medical is a privately funded clinical stage biotechnology company developing tumor-targeted precision therapies based on the new platform Photoimmunotherapy (PIT). PIT is unique in that it combines key advantages of molecular targeting of the cancer cells to achieve high tumor specificity, together with a biophysical mechanism activated at the tumor site to induce rapid cancer cell death.
Rakuten Medical’s first Investigational Medical Product based on the PIT platform, ASP-1929, is advancing into a global Phase 3 study to treat patients with recurrent Head and Neck Cancer.
Transforming the Lives of Patients
We are for the Patients and their Families.
CONQUERING Cancer. For LIFE. This is our Mission.
The patients are our inspiration and the source of our determination to translate scientific innovation into transformative treatments. We will create anticancer therapies to enable treatments with curative intent.
Join Rakuten Medical
Rakuten Medical, Inc. aims to discover, develop and commercialize therapies to treat cancer patients worldwide and fulfill our mission to conquer cancer. Since 2013, we have been developing new anticancer therapies based on the Photoimmunotherapy platform
We will excel because of our people. Together we learn, together we improve, together we persist, together we resolve all challenges, together we achieve.
Join our fight to CONQUER Cancer.